Annual CFI
$13.81 M
+$53.37 M+134.90%
December 31, 2023
Summary
- As of March 13, 2025, OMIC annual cash flow from investing activities is $13.81 million, with the most recent change of +$53.37 million (+134.90%) on December 31, 2023.
- During the last 3 years, OMIC annual CFI has fallen by -$10.20 million (-42.48%).
- OMIC annual CFI is now -42.48% below its all-time high of $24.00 million, reached on December 31, 2020.
Performance
OMIC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$42.29 M
+$18.33 M+76.49%
September 30, 2024
Summary
- As of March 13, 2025, OMIC quarterly cash flow from investing activities is $42.29 million, with the most recent change of +$18.33 million (+76.49%) on September 30, 2024.
- Over the past year, OMIC quarterly CFI has increased by +$41.64 million (+6396.62%).
- OMIC quarterly CFI is now -42.02% below its all-time high of $72.94 million, reached on March 31, 2023.
Performance
OMIC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$98.49 M
+$67.00 M+212.75%
September 30, 2024
Summary
- As of March 13, 2025, OMIC TTM cash flow from investing activities is $98.49 million, with the most recent change of +$67.00 million (+212.75%) on September 30, 2024.
- Over the past year, OMIC TTM CFI has increased by +$84.68 million (+613.31%).
- OMIC TTM CFI is now at all-time high.
Performance
OMIC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OMIC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +134.9% | +6396.6% | +613.3% |
| 3 y3 years | -42.5% | +6396.6% | +613.3% |
| 5 y5 years | +143.8% | +6396.6% | +613.3% |
OMIC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.5% | -42.0% | +211.0% | at high | +175.3% |
| 5 y | 5-year | -42.5% | +110.5% | -42.0% | +146.8% | at high | +175.3% |
| alltime | all time | -42.5% | +110.5% | -42.0% | +146.8% | at high | +175.3% |
Singular Genomics Systems Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $42.29 M(+76.5%) | $98.49 M(+212.7%) |
| Jun 2024 | - | $23.96 M(-24.1%) | $31.49 M(-214.3%) |
| Mar 2024 | - | $31.58 M(+4750.8%) | -$27.56 M(-299.6%) |
| Dec 2023 | $13.81 M(-134.9%) | $651.00 K(-102.6%) | $13.81 M(+3.6%) |
| Sep 2023 | - | -$24.70 M(-29.6%) | $13.33 M(<-9900.0%) |
| Jun 2023 | - | -$35.09 M(-148.1%) | -$87.00 K(-100.3%) |
| Mar 2023 | - | $72.94 M(>+9900.0%) | $24.99 M(-163.2%) |
| Dec 2022 | -$39.57 M | $171.00 K(-100.4%) | -$39.57 M(-37.3%) |
| Sep 2022 | - | -$38.12 M(+280.9%) | -$63.06 M(+105.7%) |
| Jun 2022 | - | -$10.01 M(-219.3%) | -$30.65 M(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $8.39 M(-136.0%) | -$32.01 M(-75.5%) |
| Dec 2021 | -$130.86 M(-645.1%) | -$23.32 M(+308.6%) | -$130.86 M(+31.0%) |
| Sep 2021 | - | -$5.71 M(-49.8%) | -$99.88 M(+14.0%) |
| Jun 2021 | - | -$11.37 M(-87.4%) | -$87.63 M(+27.3%) |
| Mar 2021 | - | -$90.46 M(-1281.7%) | -$68.85 M(-386.8%) |
| Dec 2020 | $24.00 M(-176.2%) | $7.66 M(+16.9%) | $24.00 M(+46.8%) |
| Sep 2020 | - | $6.55 M(-11.6%) | $16.35 M(+66.8%) |
| Jun 2020 | - | $7.41 M(+209.1%) | $9.80 M(+309.1%) |
| Mar 2020 | - | $2.40 M | $2.40 M |
| Dec 2019 | -$31.50 M | - | - |
FAQ
- What is Singular Genomics Systems annual cash flow from investing activities?
- What is the all time high annual CFI for Singular Genomics Systems?
- What is Singular Genomics Systems annual CFI year-on-year change?
- What is Singular Genomics Systems quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly CFI year-on-year change?
- What is Singular Genomics Systems TTM cash flow from investing activities?
- What is the all time high TTM CFI for Singular Genomics Systems?
- What is Singular Genomics Systems TTM CFI year-on-year change?
What is Singular Genomics Systems annual cash flow from investing activities?
The current annual CFI of OMIC is $13.81 M
What is the all time high annual CFI for Singular Genomics Systems?
Singular Genomics Systems all-time high annual cash flow from investing activities is $24.00 M
What is Singular Genomics Systems annual CFI year-on-year change?
Over the past year, OMIC annual cash flow from investing activities has changed by +$53.37 M (+134.90%)
What is Singular Genomics Systems quarterly cash flow from investing activities?
The current quarterly CFI of OMIC is $42.29 M
What is the all time high quarterly CFI for Singular Genomics Systems?
Singular Genomics Systems all-time high quarterly cash flow from investing activities is $72.94 M
What is Singular Genomics Systems quarterly CFI year-on-year change?
Over the past year, OMIC quarterly cash flow from investing activities has changed by +$41.64 M (+6396.62%)
What is Singular Genomics Systems TTM cash flow from investing activities?
The current TTM CFI of OMIC is $98.49 M
What is the all time high TTM CFI for Singular Genomics Systems?
Singular Genomics Systems all-time high TTM cash flow from investing activities is $98.49 M
What is Singular Genomics Systems TTM CFI year-on-year change?
Over the past year, OMIC TTM cash flow from investing activities has changed by +$84.68 M (+613.31%)